<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00244205</url>
  </required_header>
  <id_info>
    <org_study_id>Blæretumor PCR projekt</org_study_id>
    <nct_id>NCT00244205</nct_id>
  </id_info>
  <brief_title>Identifying Methylation Biomarkers for Monitoring Bladder Tumors</brief_title>
  <official_title>Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Copenhagen University Hospital at Herlev</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Copenhagen University Hospital at Herlev</source>
  <brief_summary>
    <textblock>
      To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue
      biopsies, in order to find methylation markers for use in a noninvasive test in monitoring
      patients with bladder tumors.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2005</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Case Control</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>120</enrollment>
  <condition>Bladder Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Identifying genes methylated in urine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with bladder tumors and patients with benign urinary tract conditions with no
             clinical suspicion of bladder cancer.

        Exclusion Criteria:

          -  Patients with competing urinary and systemic diseases, pregnant and patients under 18
             years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reza R Serizawa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Copenhagen University Hospital at Herlev</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reza R Serizawa, MD</last_name>
    <phone>+45 44884787</phone>
    <phone_ext>82607</phone_ext>
    <email>rerase01@herlevhosp.kbhamt.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jørgen H Andersen</last_name>
    <email>johvan01@herlevhosp.kbhamt.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Copenhagen University Hospital at Herlev</name>
      <address>
        <city>Herlev</city>
        <state>Copenhagen</state>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reza R Serizawa, MD</last_name>
      <phone>+45 4488 4787</phone>
      <phone_ext>82607</phone_ext>
      <email>rerase01@herlevhosp.kbhamt.dk</email>
    </contact>
    <investigator>
      <last_name>Reza R Serizawa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2005</study_first_submitted>
  <study_first_submitted_qc>October 24, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2005</study_first_posted>
  <last_update_submitted>November 14, 2005</last_update_submitted>
  <last_update_submitted_qc>November 14, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

